Cargando…

Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis

PURPOSE: This study aims to discuss the function mechanism of regulatory T cells and its subsets in the pathogenic process of myasthenia gravis by contracting the activation levels of those cells in peripheral blood among healthy people, patients with ocular myasthenia gravis (oMG) and patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Jie, Li, Siyu, Wang, Xinyu, Cheng, Qi, Ji, Yu, Fu, Wenwen, Huang, Hui, Shi, Ling, Wu, Xiaorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218215/
https://www.ncbi.nlm.nih.gov/pubmed/35755064
http://dx.doi.org/10.3389/fmed.2022.851808
_version_ 1784731833004457984
author Rao, Jie
Li, Siyu
Wang, Xinyu
Cheng, Qi
Ji, Yu
Fu, Wenwen
Huang, Hui
Shi, Ling
Wu, Xiaorong
author_facet Rao, Jie
Li, Siyu
Wang, Xinyu
Cheng, Qi
Ji, Yu
Fu, Wenwen
Huang, Hui
Shi, Ling
Wu, Xiaorong
author_sort Rao, Jie
collection PubMed
description PURPOSE: This study aims to discuss the function mechanism of regulatory T cells and its subsets in the pathogenic process of myasthenia gravis by contracting the activation levels of those cells in peripheral blood among healthy people, patients with ocular myasthenia gravis (oMG) and patients with generalized myasthenia gravis (gMG). METHOD: Healthy people, newly diagnosed oMG patients, and gMG patients were enrolled in this study. The percentage of the CD3(+)CD4(+)CD25(+) Treg cells, CD3(+)CD4(+)CD25(+)Foxp3(+) Treg cells, CD3(+)CD4(+)CD25(+)Foxp3(hi) CD45RA(–)aTreg cells, CD3(+)CD4(+)CD25(+)Foxp3(lo)CD45RA(–)n-sTreg cells, and CD3(+)CD4(+)CD25(+) Foxp3(lo)CD45RA(+)rTreg cells in the peripheral blood were examined by flow cytometry. And then analyzed the differences of Treg cells and its subsets among the study members. RESULTS: The percentage of the CD4(+)CD25(+)Treg cells in the peripheral blood of oMG patients and gMG patients were both lower than that of healthy people (p < 0.05), the percentage of patients with oMG had no distinct difference with that of patients with gMG (p = 0.475), however. Also, the percentage of CD3(+)CD4(+)CD25(+)Foxp3(+)Treg cells in the oMG and gMG patients’ group were both lower than that of healthy group. And the percentage of CD25(+)Foxp3(+)Treg cells in the peripheral blood of patients with oMG and healthy people were both higher than that of patients with gMG (p < 0.05). The percentage of rTreg in the CD3(+)CD4(+)CD25(+)Treg of the peripheral blood for both gMG and oMG patients’ group were lower than healthy group (p < 0.05), but there was no statistical significance between the oMG and gMG patients’ group (p = 0.232). The percentage of the aTreg cells in the CD3(+)CD4(+)CD25(+)Treg cells of the peripheral blood for the oMG patients was higher than that of gMG patients (p < 0.05), but both of them were lower than healthy group (p < 0.05). The percentage of n-sTreg cells in the peripheral blood descended among the gMG patients’ group, oMG patients’ group, and healthy group (p < 0.05). CONCLUSION: The changes in the number and function of Treg cells and its subsets can cause the impairment of negative immune regulation, which may mediate the triggering of oMG and its progression to gMG.
format Online
Article
Text
id pubmed-9218215
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92182152022-06-24 Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis Rao, Jie Li, Siyu Wang, Xinyu Cheng, Qi Ji, Yu Fu, Wenwen Huang, Hui Shi, Ling Wu, Xiaorong Front Med (Lausanne) Medicine PURPOSE: This study aims to discuss the function mechanism of regulatory T cells and its subsets in the pathogenic process of myasthenia gravis by contracting the activation levels of those cells in peripheral blood among healthy people, patients with ocular myasthenia gravis (oMG) and patients with generalized myasthenia gravis (gMG). METHOD: Healthy people, newly diagnosed oMG patients, and gMG patients were enrolled in this study. The percentage of the CD3(+)CD4(+)CD25(+) Treg cells, CD3(+)CD4(+)CD25(+)Foxp3(+) Treg cells, CD3(+)CD4(+)CD25(+)Foxp3(hi) CD45RA(–)aTreg cells, CD3(+)CD4(+)CD25(+)Foxp3(lo)CD45RA(–)n-sTreg cells, and CD3(+)CD4(+)CD25(+) Foxp3(lo)CD45RA(+)rTreg cells in the peripheral blood were examined by flow cytometry. And then analyzed the differences of Treg cells and its subsets among the study members. RESULTS: The percentage of the CD4(+)CD25(+)Treg cells in the peripheral blood of oMG patients and gMG patients were both lower than that of healthy people (p < 0.05), the percentage of patients with oMG had no distinct difference with that of patients with gMG (p = 0.475), however. Also, the percentage of CD3(+)CD4(+)CD25(+)Foxp3(+)Treg cells in the oMG and gMG patients’ group were both lower than that of healthy group. And the percentage of CD25(+)Foxp3(+)Treg cells in the peripheral blood of patients with oMG and healthy people were both higher than that of patients with gMG (p < 0.05). The percentage of rTreg in the CD3(+)CD4(+)CD25(+)Treg of the peripheral blood for both gMG and oMG patients’ group were lower than healthy group (p < 0.05), but there was no statistical significance between the oMG and gMG patients’ group (p = 0.232). The percentage of the aTreg cells in the CD3(+)CD4(+)CD25(+)Treg cells of the peripheral blood for the oMG patients was higher than that of gMG patients (p < 0.05), but both of them were lower than healthy group (p < 0.05). The percentage of n-sTreg cells in the peripheral blood descended among the gMG patients’ group, oMG patients’ group, and healthy group (p < 0.05). CONCLUSION: The changes in the number and function of Treg cells and its subsets can cause the impairment of negative immune regulation, which may mediate the triggering of oMG and its progression to gMG. Frontiers Media S.A. 2022-06-09 /pmc/articles/PMC9218215/ /pubmed/35755064 http://dx.doi.org/10.3389/fmed.2022.851808 Text en Copyright © 2022 Rao, Li, Wang, Cheng, Ji, Fu, Huang, Shi and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Rao, Jie
Li, Siyu
Wang, Xinyu
Cheng, Qi
Ji, Yu
Fu, Wenwen
Huang, Hui
Shi, Ling
Wu, Xiaorong
Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis
title Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis
title_full Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis
title_fullStr Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis
title_full_unstemmed Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis
title_short Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis
title_sort comparison of peripheral blood regulatory t cells and functional subsets between ocular and generalized myasthenia gravis
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218215/
https://www.ncbi.nlm.nih.gov/pubmed/35755064
http://dx.doi.org/10.3389/fmed.2022.851808
work_keys_str_mv AT raojie comparisonofperipheralbloodregulatorytcellsandfunctionalsubsetsbetweenocularandgeneralizedmyastheniagravis
AT lisiyu comparisonofperipheralbloodregulatorytcellsandfunctionalsubsetsbetweenocularandgeneralizedmyastheniagravis
AT wangxinyu comparisonofperipheralbloodregulatorytcellsandfunctionalsubsetsbetweenocularandgeneralizedmyastheniagravis
AT chengqi comparisonofperipheralbloodregulatorytcellsandfunctionalsubsetsbetweenocularandgeneralizedmyastheniagravis
AT jiyu comparisonofperipheralbloodregulatorytcellsandfunctionalsubsetsbetweenocularandgeneralizedmyastheniagravis
AT fuwenwen comparisonofperipheralbloodregulatorytcellsandfunctionalsubsetsbetweenocularandgeneralizedmyastheniagravis
AT huanghui comparisonofperipheralbloodregulatorytcellsandfunctionalsubsetsbetweenocularandgeneralizedmyastheniagravis
AT shiling comparisonofperipheralbloodregulatorytcellsandfunctionalsubsetsbetweenocularandgeneralizedmyastheniagravis
AT wuxiaorong comparisonofperipheralbloodregulatorytcellsandfunctionalsubsetsbetweenocularandgeneralizedmyastheniagravis